<h4>Background and aim</h4>The C-reactive protein-albumin-lymphocyte (CALLY) index is an emerging biomarker, yet, its potential association with all-cause mortality risk in patients with depression remains unexplored. The gene discussed is CRP; the disease is depressive symptom measurement.